Form 6-K TAKEDA PHARMACEUTICAL For: Sep 14
FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or 15d-16 ofthe Securities Exchange Act of 1934For the month of September 2026 Commission File Number: 001-38757TAKEDA PHARMACEUTICAL COMPANY LIMITED(Translation of registrant’s name into English)1-1, Nihonbashi-Honcho 2-ChomeChuo-ku, Tokyo 103-8668Japan(Address of principal executive offices)Indicate by check mark whether the registrant files... (continue reading...)
Form 6-K PRUDENTIAL PLC For: Sep 14
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the
month of September, 2026
PRUDENTIAL PUBLIC LIMITED COMPANY
(Translation
of registrant's name into English)
15/F, One International Finance Centre,
1 Harbour View Street, Central,
Hong Kong, China
(Address
of principal executive... (continue reading...)
Form D/A Bin Yuan Greater China
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 424B2 AMERICAN INTERNATIONAL
TABLE OF CONTENTS
The information in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary prospectus supplement nor the accompanying prospectus is an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Filed Pursuant to Rule 424(b)(2)
... (continue reading...)
Form 497K HARDING LOEVNER FUNDS
Harding, Loevner Funds, Inc.
Supplement dated September 14, 2026 to the
Summary Prospectuses (the “Summary Prospectuses”), each dated February 28, 2026, as supplemented, for:
Frontier Emerging Markets Portfolio (Investor Class, Institutional Class, and Institutional Class Z) and Institutional Emerging Markets Portfolio (Institutional and Institutional Class Z)
Prospectus for Institutional Investors, Prospectus for Individual Investors and Prospectus for... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K ADDENTAX GROUP CORP. For: Sep 14
-
Form 8-K Perspective Therapeutics For: Sep 14
-
Form 497K HARDING LOEVNER FUNDS
-
Form 6-K VinFast Auto Ltd. For: Sep 14
-
Form 497 HARDING LOEVNER FUNDS
-
Form 424B2 Vistra Operations Co
-
Form 8-K Embrace Change Acquisiti For: Sep 10
-
Form 8-K Lipocine Inc. For: Sep 14
-
Form D/A Bin Yuan Greater China
-
Form D/A L&R ASIA CREDIT ALPHA
-
Form 6-K NOVONIX Ltd For: Sep 14
-
Form 6-K Radiopharm Theranostics For: Sep 14
-
Form 425 Translational Developmen Filed by: Prologium Holding Inc.
-
Form 6-K Zhihu Inc. For: Sep 14
-
Form 6-K Clearmind Medicine Inc. For: Sep 14
-
Form F-3 Radiopharm Theranostics
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 6-K Li Auto Inc. For: Sep 14
-
Form D/A Sage Partners Alpha 1
-
Form SCHEDULE 13G/A Grab Holdings Ltd Filed by: TOYOTA MOTOR CORP/
-
Form 3 Polar Power, Inc. For: Aug 17 Filed by: Ahern Jim
-
Form SCHEDULE 13G Safe Pro Group Inc. Filed by: FROST PHILLIP MD ET AL
-
Form 8-K WhiteFiber, Inc. For: Sep 14
-
Form 6-K PRUDENTIAL PLC For: Sep 14
-
Form S-1/A Electra Therapeutics,
-
Form 4 Alibaba Group Holding For: Sep 10 Filed by: Wu Yongming
-
Form 1-SA McQueen Labs Series, For: Jun 30
-
Form C/A Oravanti Ventures Inc
-
Form S-3ASR Tyra Biosciences, Inc.
-
Form DEF 14C SHARING ECONOMY INTERNAT For: Sep 14
-
Form 424B2 Jefferies Financial Grou
-
Form 6-K WOODSIDE ENERGY GROUP For: Sep 14
-
Form 15-12G Apogee Therapeutics,
-
Form 8-K Artificial Intelligence For: Sep 14
-
Form EFFECT ACCURAY INC
-
Form 6-K Biophytis SA For: Sep 11
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 6-K KE Holdings Inc. For: Sep 14
-
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 11 Filed by: Heshmatpour Amir F
-
Form EFFECT Eightco Holdings Inc.
-
Form EFFECT Wheeler Real Estate Inve
-
Form 6-K Nanobiotix S.A. For: Sep 14
-
Form EFFECT Strategic Storage Trust
-
Form EFFECT VS MEDIA Holdings Ltd
-
Form EFFECT Indivior Pharmaceuticals
-
Form 8-K ORACLE CORP For: Sep 12
-
Form 6-K NOMURA HOLDINGS INC For: Sep 14
